The AI In Precision Medicine Market is being driven by Proliferation of Large Scale, Multi-Modal Healthcare Data
The AI In Precision Medicine Market is expected to grow at a CAGR of 21.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 880.7 million. The AI in precision medicine market is witnessing a significant shift with the increasing adoption of generative AI technology. Unlike traditional AI models that focus on data analysis and interpretation, generative AI creates novel, synthetic data, revolutionizing drug discovery and development. This capability is being leveraged to design new molecules, predict protein structures, and expedite preclinical research phases in pharmaceuticals. Notable technology giants and pharmaceutical companies are investing and forming strategic partnerships to harness this trend, marking a paradigm shift from using AI for data analysis to utilizing it as a creative partner in scientific innovation.
Get more information on AI In Precision Medicine Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
250 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 21.3% |
Market growth 2025-2029 |
USD 880.7 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
18.9 |
Key countries |
US, Canada, Germany, UK, France, Italy, Japan, South Korea, China, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
In the realm of Precision Medicine, AI is revolutionizing various aspects, including the validation of AI algorithms and biomarkers, clinical trial simulations, drug target identification, patient stratification, and treatment pathway optimization. AI is also enhancing personalized cancer therapy through disease risk prediction, medical image segmentation, and diagnostic accuracy improvement. Additionally, it's being integrated into telemedicine platforms, sensor data fusion, and data visualization tools for clinical workflow improvement. AI applications extend to pharmacovigilance, drug efficacy and clinical outcome prediction, oncology clinical trials, rare disease diagnostics, genetic risk assessment, radiomics feature extraction, and digital pathology analysis. Decision support systems, evidence-based medicine AI, ethical considerations AI, bias mitigation AI, and model interpretability are essential components ensuring trust and accuracy in AI applications in Precision Medicine. Data privacy regulations remain a crucial consideration throughout AI implementation.
In the dynamic and innovative landscape of IT software, the application software segment holds significant importance, particularly within the niche area of Precision Medicine. This sector encompasses machine learning diagnostics, deep learning biomarkers, genomic data integration, and precision oncology treatment. Companies excelling in these specialized applications contribute to this segment, which is a subset of the larger IT software market. The global application software market for Precision Medicine includes providers of enterprise and technical software, as well as cloud-based solutions. These companies are instrumental in revolutionizing healthcare through advanced technologies, improving patient outcomes and personalizing treatment plans.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted